Epigenetic dysregulation in neurodegenerative diseases and potential treatment

Epigenetic dysregulation in neurodegenerative diseases and potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Библиографические подробности
Главный автор:	Mostofa, Golam
Другие авторы:	Khan, Tanisha Tabassum Sayka
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2022
Предметы:	Epigenetics Dysregulation Methylation Acetylation Alzheimer’s disease Parkinson’s disease Huntington’s disease Epidrugs
Online-ссылка:	http://hdl.handle.net/10361/17309

Схожие документы

Potential treatments for epigenetic dysregulation in neurological diseases
по: Zaman, Rubaiyat
Опубликовано: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
по: Dey, Manashi
Опубликовано: (2024)

Gene editing for neurodegenerative diseases-A review
по: Sharna, Anika Islam
Опубликовано: (2023)

Role of epigenetics in the development of metabolic disorders: a review
по: Mita, Tanzia Mohsin
Опубликовано: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
по: Annee, Israt Jahan
Опубликовано: (2023)

Role of circular RNA in neurological disease
по: Salsabil, Labiba
Опубликовано: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
по: Afsana, Nourin
Опубликовано: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
по: Ferdous, Labiba
Опубликовано: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
по: Chowdhury, Sariya Uzrat
Опубликовано: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
по: Tabassum, Nadira
Опубликовано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

A review on cardiovascular development and epigenetics
по: Srity, Nafisa Alam
Опубликовано: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
по: Shehab, Habibul Mohsin
Опубликовано: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
по: Afreen, Nuraia
Опубликовано: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
по: Tamanna, Mst. Taskia
Опубликовано: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
по: Karmaker, Swastika
Опубликовано: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
по: Tasneem, Sadia
Опубликовано: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
по: Saha, Bithi Rani
Опубликовано: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
по: Chowdhury, Amal
Опубликовано: (2024)

Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
по: Abedin, Khondokar Mezbahul
Опубликовано: (2023)

Alzheimer's disease and marriage : an intimate account /
по: Wright, Lore K.
Опубликовано: (1993)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
по: Key, Nasrin Sultana
Опубликовано: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
по: Tasin, Md Abtahi
Опубликовано: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
по: Aziz, Farhin
Опубликовано: (2019)

Early detection of parkinson’s disease using image processing and artificial neural network
по: Rumman, Mosarrat, и др.
Опубликовано: (2018)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
по: Afra, Sumaiya
Опубликовано: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
по: Mahee, Sadique Abdal
Опубликовано: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
по: Islam, Md. Rakibul
Опубликовано: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
по: Halim, Rabea
Опубликовано: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
по: Aana, Afsara Sumon
Опубликовано: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
по: Jahan, Nusrat
Опубликовано: (2023)

Infection and communicable diseases /
по: Brettle, Raymond Patrick
Опубликовано: (1984)

Exploring Alzheimer's disease prediction with XAI in various neural network models
по: Rahman, Quazi Ashikur, и др.
Опубликовано: (2022)

Exploring the potential of organic molecules in the treatment of covid-19
по: Mondol, Winifred Claire
Опубликовано: (2024)